汇宇制药公布半年报 上半年净利减少223.78%

Group 1 - The core viewpoint of the article is that Huiyu Pharmaceutical has reported a significant decline in both revenue and net profit for the first half of the year [1] - The company's operating revenue for the first half of the year is 453,118,838.70 yuan, representing a year-on-year decrease of 14.86% [1] - The net profit attributable to shareholders of the listed company is -80,720,507.81 yuan, which shows a year-on-year decrease of 223.78% [1] Group 2 - Among the top ten circulating shareholders, Lang Zhijiang is identified as a new circulating shareholder [1]